0.3177
7667766266
x

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

iasparliament Logo
January 23, 2026

Prelims: Current events of national and international importance | Health 

Why in News?

Recently, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has been emerging as a major public health concern in India.

  • About – MASLD is a metabolic liver disorder characterised by excessive fat accumulation in the liver.
  • Earlier termed as Nonalcoholic Fatty Liver Disease (NAFLD).
  • The new term highlights that the disease is a metabolic one, linked to factors such as obesity, diabetes, and high cholesterol.
  • Symptoms – It is often a silent disease with no symptoms in the early stages.
  • As it progresses, it can cause liver inflammation and long-term damage with the risk of liver failure and liver cancer.
  • Causes – It is caused by metabolic dysfunction associated with obesity, Type 2 diabetes, high blood pressure, and high cholesterol.
  • Vulnerable populations Overweight or obese persons, People with Type 2 diabetes, Individuals with high blood pressure, Persons with high cholesterol levels, middle-aged and older adults and physically inactive or sedentary individuals.
  • Progression Stages - Steatosis - It initially presents as simple steatosis, where fat accumulates in the liver without causing significant inflammation.
  • Steatohepatitis - The disease can progress to steatohepatitis, a more severe stage characterized by inflammation (MASH, formerly NASH) of the liver cells.
  • Fibrosis - This inflammation can lead to the formation of scar tissue, a process known as fibrosis.
  • Cirrhosis - As fibrosis becomes extensive, it can lead to cirrhosis, a late-stage condition where the liver is permanently scarred and unable to function properly.
  • Hepatocellular carcinoma (liver cancer)- At this point, the risk of liver failure and hepatocellular carcinoma (liver cancer) becomes extremely high.

MASLD

  • Diagnosis – Initial clues come from blood tests and liver function tests.
  • Imaging techniques like ultrasound and FibroScan help assess liver fat and fibrosis non-invasively.
  • Treatment – MASLD is a highly manageable disease, primarily through lifestyle changes, especially weight loss and regular physical activity.
  • Managing diabetes and high cholesterol is also essential.

References

  1. TH | MASLD
  2. NCIB | MASLD
Login or Register to Post Comments
There are no reviews yet. Be the first one to review.

ARCHIVES

MONTH/YEARWISE ARCHIVES

sidetext
Free UPSC Interview Guidance Programme
sidetext